NDC 16571-856 – Pentoxifylline

Pentoxifylline 400 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug

Product NDC16571-856

Product details

Brand name
Pentoxifylline
Generic name
Pentoxifylline
Labeler
Rising Pharma Holdings, Inc.
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA074425
Marketed since
June 11, 2024
Listing expires
December 31, 2027
Pharmacologic class
Blood Viscosity Reducer

Active ingredients

Uses, dosage, side effects and warnings for Pentoxifylline →

Package NDC codes (5)

Package NDCDescriptionSince
16571-856-01100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-01)Jun 5, 2026
16571-856-0550 BLISTER PACK in 1 CARTON (16571-856-05) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACKJun 5, 2026
16571-856-1110 BLISTER PACK in 1 CARTON (16571-856-11) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACKJun 5, 2026
16571-856-50500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-50)Jun 5, 2026
16571-856-901 BLISTER PACK in 1 CARTON (16571-856-90) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACKJun 5, 2026

Other Pentoxifylline products